Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia

Schizophrenia Research

Volumn 154, Issue 1-3, 2014, Pages 1-13

  Shan, Dan ^a   Mount, Daniel ^a   Moore, Stephen ^b   Haroutunian, Vahram ^c   Meador Woodruff, James H ^a,d   McCullumsmith, Robert E ^e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Civitan International Research Center Evelyn F McKnight Brain Institute University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Dorsolateral prefrontal cortex (DLPFC); Excitatory amino acid transporter (EAAT); Immunoisolation; Mass spectrometry; Postmortem; Reuptake

Indexed keywords

ACONITASE 1; ACONITASE 2; ACONITATE HYDRATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 2B; GLUTAMATE TRANSPORTER; HEXOKINASE 1; MITOCHONDRIAL PROTEIN; UNCLASSIFIED DRUG; ACO2 PROTEIN, HUMAN; HEXOKINASE; HK1 PROTEIN, HUMAN; IRON REGULATORY PROTEIN 1; ISOENZYME; ISOPROTEIN; SLC1A2 PROTEIN, HUMAN;

ARTICLE; AUTOPSY; CELL FRACTIONATION; CONTROLLED STUDY; EXON; HUMAN; HUMAN CELL; HUMAN TISSUE; MASS SPECTROMETRY; MITOCHONDRION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; SCHIZOPHRENIA; SYNAPTIC MEMBRANE; CELL MEMBRANE; ELECTRON MICROSCOPY; ENZYMOLOGY; GENETICS; LIQUID CHROMATOGRAPHY; METABOLISM; PATHOLOGY; TANDEM MASS SPECTROMETRY; ULTRASTRUCTURE; WESTERN BLOTTING;

ACONITATE HYDRATASE; BLOTTING, WESTERN; CELL MEMBRANE; CHROMATOGRAPHY, LIQUID; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; HEXOKINASE; HUMANS; IRON REGULATORY PROTEIN 1; ISOENZYMES; MICROSCOPY, ELECTRON; MITOCHONDRIA; PREFRONTAL CORTEX; PROTEIN ISOFORMS; SCHIZOPHRENIA; SODIUM-POTASSIUM-EXCHANGING ATPASE; TANDEM MASS SPECTROMETRY;

EID: 84897026429     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.01.028     Document Type: Article

References (74)

1. Abu-Hamad S., Zaid H., Israelson A., Nahon E., Shoshan-Barmatz V. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding. J. Biol. Chem. 2008, 283(19):13482-13490.
2. Tretter L., Adam-Vizi V. Inhibition of krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J Neurosci. 2000, 20(24):8972-8979.
3. +)-ATPase in cultured cells. Biochim. Biophys. Acta 1984, 804(4):419-426.
4. Bar-Peled O., Ben-Hur H., Biegon A., Groner Y., Dewhurst S., Furuta A., Rothstein J.D. Distribution of glutamate transporter subtypes during human brain development. J. Neurochem. 1997, 69(6):2571-2580.
5. Bauer D., Gupta D., Harotunian V., Meador-Woodruff J.H., McCullumsmith R.E. Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia. Schizophr. Res. 2008, 104(1-3):108-120.
6. Bauer D., Haroutunian V., Meador-Woodruff J.H., McCullumsmith R.E. Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia. Schizophr. Res. 2010, 117(1):92-98.
7. Beasley T.M., Holt J.K., Allison D.B. Comparison of linear weighting schemes for perfect match and mismatch gene expression levels from microarray data. Am. J. Pharmacogenomics 2005, 5(3):197-205.
8. Bergeron R., Coyle J.T. NAAG, NMDA receptor and psychosis. Curr. Med. Chem. 2012, 19(9):1360-1364.
9. Bhugra D. The global prevalence of schizophrenia. PLoS Med. 2005, 2(5):e151. (quiz e175).
10. Bjornsen L.P., Eid T., Holmseth S., Danbolt N.C., Spencer D.D., de Lanerolle N.C. Changes in glial glutamate transporters in human epileptogenic hippocampus: inadequate explanation for high extracellular glutamate during seizures. Neurobiol. Dis. 2007, 25(2):319-330.
11. Blanco G., Mercer R.W. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am. J. Physiol. 1998, 275(5 Pt 2):F633-F650.
12. Bubber P., Hartounian V., Gibson G.E., Blass J.P. Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients. Eur. Neuropsychopharmacol. 2011, 21(3):254-260.
13. Cameron R., Klein L., Shyjan A.W., Rakic P., Levenson R. Neurons and astroglia express distinct subsets of Na, K-ATPase alpha and beta subunits. Brain Res. Mol. Brain Res. 1994, 21(3-4):333-343.
14. Chaudhry F.A., Lehre K.P., van Lookeren Campagne M., Ottersen O.P., Danbolt N.C., Storm-Mathisen J. Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 1995, 15(3):711-720.
15. +-ATPase alpha 2 subunit and the glutamate transporters GLAST and GLT-1 in the rat somatosensory cortex. Cereb. Cortex 2002, 12(5):515-525.
16. Clinton S.M., Haroutunian V., Davis K.L., Meador-Woodruff J.H. Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia. Am. J. Psychiatry 2003, 160(6):1100-1109.
17. Clinton S.M., Meador-Woodruff J.H. Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophr. Res. 2004, 69(2-3):237-253.
18. Dalman M.R., Deeter A., Nimishakavi G., Duan Z.H. Fold change and p-value cutoffs significantly alter microarray interpretations. BMC Bioinforma. 2012, 13(Suppl. 2):S11.
19. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65(1):1-105.
20. De Souza I.E., McBean G.J., Meredith G.E. Chronic haloperidol treatment impairs glutamate transport in the rat striatum. Eur. J. Pharmacol. 1999, 382(2):139-142.
21. Furuta A., Rothstein J.D., Martin L.J. Glutamate transporter protein subtypes are expressed differentially during rat CNS development. J. Neurosci. 1997, 17(21):8363-8375.
22. Genda E.N., Jackson J.G., Sheldon A.L., Locke S.F., Greco T.M., O'Donnell J.C., Spruce L.A., Xiao R., Guo W., Putt M., Seeholzer S., Ischiropoulos H., Robinson M.B. Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria. J. Neurosci. 2011, 31(50):18275-18288.
23. Ginsberg S.D., Martin L.J., Rothstein J.D. Regional differentiation down-regulates subtypes of glutamate transporter proteins. J. Neurochem. 1995, 65(6):2800-2803.
24. Hammond J.C., Meador-Woodruff J.H., Haroutunian V., McCullumsmith R.E. AMPA receptor subunit expression in the endoplasmic reticulum in frontal cortex of elderly patients with schizophrenia. PLoS One 2012, 7(6):e39190.
25. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999, 122(Pt 4):593-624.
26. Hundal H.S., Maxwell D.L., Ahmed A., Darakhshan F., Mitsumoto Y., Klip A. Subcellular distribution and immunocytochemical localization of Na, K-ATPase subunit isoforms in human skeletal muscle. Mol. Membr. Biol. 1994, 11(4):255-262.
27. Ikeda K., Onaka T., Yamakado M., Nakai J., Ishikawa T.O., Taketo M.M., Kawakami K. Degeneration of the amygdala/piriform cortex and enhanced fear/anxiety behaviors in sodium pump alpha2 subunit (Atp1a2)-deficient mice. J. Neurosci. 2003, 23(11):4667-4676.
28. Ikematsu K., Tsuda R., Orihara Y., Nakasono I. The expression of excitatory amino acid transporter 2 (EAAT2) in forensic autopsy cases. Forensic Sci. Int. 2001, 118(1):49-55.
29. Kalandadze A., Wu Y., Fournier K., Robinson M.B. Identification of motifs involved in endoplasmic reticulum retention-forward trafficking of the GLT-1 subtype of glutamate transporter. J. Neurosci. 2004, 24(22):5183-5192.
30. Kantrowitz J., Javitt D.C. Glutamatergic transmission in schizophrenia: from basic research to clinical practice. Curr. Opin. Psychiatry 2012, 25(2):96-102.
31. Kaplan J.H. Biochemistry of Na, K-ATPase. Annu. Rev. Biochem. 2002, 71:511-535.
32. Karlsson R.M., Tanaka K., Saksida L.M., Bussey T.J., Heilig M., Holmes A. Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia. Neuropsychopharmacology 2009, 34(6):1578-1589.
33. Kawakami K., Ikeda K. Modulation of neural activities by Na, K-ATPase alpha 2 subunit through functional coupling with transporters. Cell. Mol. Biol. Incl. Cyto-Enzymol. 2006, 52(8):92-96.
34. Kristiansen L.V., Huerta I., Beneyto M., Meador-Woodruff J.H. NMDA receptors and schizophrenia. Curr. Opin. Pharmacol. 2007, 7(1):48-55.
35. Kugler P., Schmitt A. Glutamate transporter EAAC1 is expressed in neurons and glial cells in the rat nervous system. Glia 1999, 27(2):129-142.
36. Larsson H.P., Wang X., Lev B., Baconguis I., Caplan D.A., Vyleta N.P., Koch H.P., Diez-Sampedro A., Noskov S.Y. Evidence for a third sodium-binding site in glutamate transporters suggests an ion/substrate coupling model. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(31):13912-13917.
37. Lauriat T.L., Dracheva S., Chin B., Schmeidler J., McInnes L.A., Haroutunian V. Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain. Neuroscience 2006, 137(3):843-851.
38. Lauriat T.L., McInnes L.A. EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders. Mol. Psychiatry 2007, 12(12):1065-1078.
39. Lehre K.P., Levy L.M., Ottersen O.P., Storm-Mathisen J., Danbolt N.C. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J. Neurosci. 1995, 15(3 Pt 1):1835-1853.
40. + uptake require glycolysis. Fed. Proc. 1983, 42(12):2875-2880.
41. +-ATPase in renal cell line MDCK. Am. J. Physiol. 1987, 253(2 Pt 1):C269-C276.
42. MacDonald S.W., Nyberg L., Backman L. Intra-individual variability in behavior: links to brain structure, neurotransmission and neuronal activity. Trends Neurosci. 2006, 29(8):474-480.
43. Macnab L.T., Pow D.V. Expression of the exon 9-skipping form of EAAT2 in astrocytes of rats. Neuroscience 2007, 150(3):705-711.
44. Magistretti P.J., Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1999, 354(1387):1155-1163.
45. Magistretti P.J., Pellerin L., Rothman D.L., Shulman R.G. Energy on demand. Science 1999, 283(5401):496-497.
46. Maragakis N.J., Dykes-Hoberg M., Rothstein J.D. Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann. Neurol. 2004, 55(4):469-477.
47. Marsman A., van den Heuvel M.P., Klomp D.W., Kahn R.S., Luijten P.R., Hulshoff Pol H.E. Glutamate in schizophrenia: a focused review and meta-analysis of (1)H-MRS studies. Schizophr. Bull. 2013, 39(1):120-129.
48. Matute C., Melone M., Vallejo-Illarramendi A., Conti F. Increased expression of the astrocytic glutamate transporter GLT-1 in the prefrontal cortex of schizophrenics. Glia 2005, 49(3):451-455.
49. McCullumsmith R.E., Meador-Woodruff J.H. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 2002, 26(3):368-375.
50. McDonough A.A., Geering K., Farley R.A. The sodium pump needs its beta subunit. FASEB J. 1990, 4(6):1598-1605.
51. Meador-Woodruff J.H., Healy D.J. Glutamate receptor expression in schizophrenic brain. Brain Res. Brain Res. Rev. 2000, 31(2-3):288-294.
52. Melone M., Vitellaro-Zuccarello L., Vallejo-Illarramendi A., Perez-Samartin A., Matute C., Cozzi A., Pellegrini-Giampietro D.E., Rothstein J.D., Conti F. The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine. Mol. Psychiatry 2001, 6(4):380-386.
53. Moseley A.E., Williams M.T., Schaefer T.L., Bohanan C.S., Neumann J.C., Behbehani M.M., Vorhees C.V., Lingrel J.B. Deficiency in Na, K-ATPase alpha isoform genes alters spatial learning, motor activity, and anxiety in mice. J. Neurosci. 2007, 27(3):616-626.
54. Ohnuma T., Augood S.J., Arai H., McKenna P.J., Emson P.C. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. Brain Res. Mol. Brain Res. 1998, 56(1-2):207-217.
55. Ohnuma T., Tessler S., Arai H., Faull R.L., McKenna P.J., Emson P.C. Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus. Brain Res. Mol. Brain Res. 2000, 85(1-2):24-31.
56. Parker J.C., Hoffman J.F. The role of membrane phosphoglycerate kinase in the control of glycolytic rate by active cation transport in human red blood cells. J. Gen. Physiol. 1967, 50(4):893-916.
57. Pellerin L., Magistretti P.J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Natl. Acad. Sci. U. S. A. 1994, 91(22):10625-10629.
58. +-ATPase activity in astrocytes via activation of a distinct subunit highly sensitive to ouabain. J. Neurochem. 1997, 69(5):2132-2137.
59. Rao J.S., Kellom M., Reese E.A., Rapoport S.I., Kim H.W. Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J. Affect. Disord. 2012, 136(1-2):63-71.
60. Regenold W.T., Pratt M., Nekkalapu S., Shapiro P.S., Kristian T., Fiskum G. Mitochondrial detachment of hexokinase 1 in mood and psychotic disorders: implications for brain energy metabolism and neurotrophic signaling. J. Psychiatr. Res. 2012, 46(1):95-104.
61. Rose E.M., Koo J.C., Antflick J.E., Ahmed S.M., Angers S., Hampson D.R. Glutamate transporter coupling to Na, K-ATPase. J. Neurosci. 2009, 29(25):8143-8155.
62. Rothman D.L., Sibson N.R., Hyder F., Shen J., Behar K.L., Shulman R.G. In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1999, 354(1387):1165-1177.
63. Rothstein J.D., Martin L., Levey A.I., Dykes-Hoberg M., Jin L., Wu D., Nash N., Kuncl R.W. Localization of neuronal and glial glutamate transporters. Neuron 1994, 13(3):713-725.
64. Schneider J.S., Wade T., Lidsky T.I. Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum. Neuroreport 1998, 9(1):133-136.
65. Shan D., Haroutunian V., Meador-Woodruff J.H., McCullumsmith R.E. Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia. Neuroreport 2012, 23(4):224-227.
66. Shan D., Lucas E.K., Drummond J.B., Haroutunian V., Meador-Woodruff J.H., McCullumsmith R.E. Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia. Schizophr. Res. 2013, 144(1-3):1-8.
67. Sheldon A.L., Robinson M.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 2007, 51(6-7):333-355.
68. Shigeri Y., Seal R.P., Shimamoto K. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res. Brain Res. Rev. 2004, 45(3):250-265.
69. Sidoryk-Wegrzynowicz M., Lee E., Aschner M. Mechanism of Mn(II)-mediated dysregulation of glutamine-glutamate cycle: focus on glutamate turnover. J. Neurochem. 2012, 122(4):856-867.
70. Smith R.E., Haroutunian V., Davis K.L., Meador-Woodruff J.H. Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am. J. Psychiatry 2001, 158(9):1393-1399.
71. Stone W.S., Faraone S.V., Su J., Tarbox S.I., Van Eerdewegh P., Tsuang M.T. Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 127B(1):5-10.
72. Tzingounis A.V., Wadiche J.I. Glutamate transporters: confining runaway excitation by shaping synaptic transmission. Nat. Rev. Neurosci. 2007, 8(12):935-947.
73. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., Stray S.M., Rippey C.F., Roccanova P., Makarov V., Lakshmi B., Findling R.L., Sikich L., Stromberg T., Merriman B., Gogtay N., Butler P., Eckstrand K., Noory L., Gochman P., Long R., Chen Z., Davis S., Baker C., Eichler E.E., Meltzer P.S., Nelson S.F., Singleton A.B., Lee M.K., Rapoport J.L., King M.C., Sebat J. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320(5875):539-543.
74. Wilson J.E. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J. Exp. Biol. 2003, 206(Pt 12):2049-2057.